Small extracellular vehicles derived from cerebral endothelial cells promote white matter remodeling and improve functional recovery following cerebral ischemia/reperfusion in aged rats
Recommended Citation
Zhang L, Luo H, Teng H, Powell B, Zhang Y, Liu X, Chopp M, Zhang Z. Small extracellular vehicles derived from cerebral endothelial cells promote white matter remodeling and improve functional recovery following cerebral ischemia/reperfusion in aged rats. Stroke 2026; 57(SUPPL_1):1.
Document Type
Conference Proceeding
Publication Date
1-29-2026
Publication Title
Stroke
Keywords
Ischemia reperfusion, Aging, Endothelial, MicroRNA, Infarction, Neurosciences & Neurology, Cardiovascular System & Cardiology
Abstract
Background: Ischemic strokes due to large vessel occlusion (LVO) predominantly affect the elderly and often result in high mortality and long-term disability. Although endovascular thrombectomy (EVT) has revolutionized LVO treatment, nearly half of patients fail to achieve functional independence despite successful reperfusion. Using a model of ischemia/reperfusion in aged rats, we tested the hypothesis that small extracellular vesicles (sEVs) derived from healthy cerebral endothelial cells (CEC-sEVs) enhance functional recovery. Methods: Aged male rats (18–20 months old) were subjected to 3h transient middle cerebral artery occlusion (MCAO) by a filament. CEC-sEVs were isolated from CEC cultures of healthy young-adult rats. Upon reperfusion (at 3h), the rats were randomly treated with CEC-sEVs (1x10 11 particles/injection) or saline administered via the internal carotid artery followed by a second dose given intravenously 24h after MCAO (n=10/group). Neurological outcomes were assessed weekly for 4 weeks with an array of behavioral tests. Results: The CEC-sEV treatment significantly reduced infarct volume by 23% and promoted neurological function recovery measured by modified neurological severity scores, foot-fault tests, and adhesive removal tests from weeks 2 to 4 post-stroke compared to the saline treated rats. Immunohistochemistry (IHC) revealed that CEC-sEVs substantially increased myelin basic proteins by 32% which is associated with significantly reduced oxidative damage in the NG2-positive oligodendrocyte progenitor cells (OPCs), as demonstrated by decreased 8-OHdG immunoreactivity (15±5% vs 26±8% of NG2-positive cells in saline) in the peri-infarct regions. Additionally, CEC-sEVs significantly increased neurofilament heavy chain positive axons by 26%. RNAseq and bioinformatics analyses showed that CEC-sEV cargo was enriched with miR-34a, -146a, -183, -202, and -450, which potentially target genes involved in cellular oxidative stress regulation. Conclusions: The CEC-sEVs treatment initiated at reperfusion substantially improved functional recovery in aged rats with 3h transient MCAO. Our IHC and CEC-sEV cargo miRNA data suggest that CEC-sEVs promote OPC differentiation into myelinating oligodendrocytes (OLs), likely by miRNA-mediated attenuation of oxidative stress, and thereby facilitating white matter remodeling after stroke. Our findings support the development of CEC-sEVs as a potential adjuvant therapy to optimize stroke outcome after EVT.
Volume
57
Issue
SUPPL_1
First Page
1
